NCT06594536View on ClinicalTrials.gov

Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

September 1, 2026

Conditions

Attention Deficit Disorder

Interventions

DIETARY_SUPPLEMENT

Sulforaphane

taken once a day (one to three capsules a day depending on the patient's weight) for 8 weeks of Sulforaphane

OTHER

Placebo

taken once a day (one to three capsules a day depending on the patient's weight) for 8 weeks of placebo

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06594536 - Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity | Biotech Hunter | Biotech Hunter